The trajectory of Sildenafil presents a interesting case for stakeholders in the drug sector. While initially a phenomenal success, creating vast sums, the exclusivity end and the subsequent entry of off-brand https://adult517936.designertoblog.com/73234550/sildenafil-and-big-pharma-a-hazardous-bet